Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study.
Reddel SW, Barnett MH, Riminton S, Dugal T, Buzzard K, Wang CT, Fitzgerald F, Beadnall HN, Erickson D, Gahan D, Wang D, Ackland T, Thompson R. Reddel SW, et al. Mult Scler. 2019 Jul;25(8):1124-1131. doi: 10.1177/1352458518783673. Epub 2018 Jun 18. Mult Scler. 2019. PMID: 29911471 Clinical Trial.
Chronic ophthalmoplegia with anti-GQ1b antibody.
Reddel SW, Barnett MH, Yan WX, Halmagyi GM, Pollard JD. Reddel SW, et al. Neurology. 2000 Feb 22;54(4):1000-2. doi: 10.1212/wnl.54.4.1000. Neurology. 2000. PMID: 10691005
Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).
Simon NG, Parratt JD, Barnett MH, Buckland ME, Gupta R, Hayes MW, Masters LT, Reddel SW. Simon NG, et al. Among authors: reddel sw. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):15-22. doi: 10.1136/jnnp-2011-301054. Epub 2011 Nov 5. J Neurol Neurosurg Psychiatry. 2012. PMID: 22056964 Review.
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA, et al. Among authors: reddel sw. J Clin Neurosci. 2014 Nov;21(11):1847-56. doi: 10.1016/j.jocn.2014.01.018. Epub 2014 Jun 28. J Clin Neurosci. 2014. PMID: 24986155 Review.
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA, et al. Among authors: reddel sw. J Clin Neurosci. 2014 Nov;21(11):1835-46. doi: 10.1016/j.jocn.2014.01.016. Epub 2014 Jun 30. J Clin Neurosci. 2014. PMID: 24993135 Review.
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists. Broadley SA, et al. Among authors: reddel sw. J Clin Neurosci. 2014 Nov;21(11):1857-65. doi: 10.1016/j.jocn.2014.01.017. Epub 2014 Jun 30. J Clin Neurosci. 2014. PMID: 24993136 Review.
Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment.
Hardy TA, O'Brien B, Gerbis N, Barnett MH, Reddel SW, Brewer J, Herkes GK, Silberstein P, Garsia RJ, Watson JD, Gupta R, Parratt JD, Buckland ME. Hardy TA, et al. Among authors: reddel sw. J Neurol Neurosurg Psychiatry. 2015 May;86(5):582-4. doi: 10.1136/jnnp-2014-308240. Epub 2014 Aug 28. J Neurol Neurosurg Psychiatry. 2015. PMID: 25168394 No abstract available.
Distinguishing Susac's syndrome from multiple sclerosis.
Buzzard KA, Reddel SW, Yiannikas C, Sean Riminton D, Barnett MH, Hardy TA. Buzzard KA, et al. Among authors: reddel sw. J Neurol. 2015 Jul;262(7):1613-21. doi: 10.1007/s00415-014-7628-9. Epub 2014 Dec 30. J Neurol. 2015. PMID: 25547511 Review.
122 results